Coinsurance vs. copayments : reimbursement rules for a monopolistic medical product with competitive health insurers - HAL-SHS - Sciences de l'Homme et de la Société Accéder directement au contenu
Pré-Publication, Document De Travail Année : 2022

Coinsurance vs. copayments : reimbursement rules for a monopolistic medical product with competitive health insurers

Résumé

This paper studies a market for a medical product in which there is perfect competition among health insurers, while the good is sold by a monopolist. Individuals di¤er in their severity of illness and there is ex post moral hazard. We consider two regimes : one in which insurers use coinsurance rates (ad valorem reimbursements) and one in which insurers use copayments (specic reimbursements). We show that the induced equilibrium with copayments involves a lower producer price and a higher level of wel- fare for consumers. This results provides strong support for a reference price based reimbursement policy.
Fichier principal
Vignette du fichier
wp_tse_1223.pdf (218.05 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03629480 , version 1 (04-04-2022)

Identifiants

  • HAL Id : hal-03629480 , version 1

Citer

Helmuth Cremer, Jean-Marie Lozachmeur. Coinsurance vs. copayments : reimbursement rules for a monopolistic medical product with competitive health insurers. 2022. ⟨hal-03629480⟩
26 Consultations
41 Téléchargements

Partager

Gmail Facebook X LinkedIn More